A Study of ASP1951 in Subjects With Advanced Solid Tumors

NCT03799003 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

119

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated for lack of efficacy.

Conditions

Advanced Solid Tumors

Interventions

DRUG: ASP1951
DRUG: pembrolizumab

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators

[object Object]